Cargando…

Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories

BACKGROUND: The SARS-CoV-2 pandemic has revealed the vulnerability of immunisation systems worldwide, although the scale of these disruptions has not been described at a global level. This study aims to assess the impact of COVID-19 on routine immunisation using triangulated data from global, countr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shet, Anita, Carr, Kelly, Danovaro-Holliday, M Carolina, Sodha, Samir V, Prosperi, Christine, Wunderlich, Joshua, Wonodi, Chizoba, Reynolds, Heidi W, Mirza, Imran, Gacic-Dobo, Marta, O'Brien, Katherine L, Lindstrand, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691849/
https://www.ncbi.nlm.nih.gov/pubmed/34951973
http://dx.doi.org/10.1016/S2214-109X(21)00512-X
_version_ 1784618834015027200
author Shet, Anita
Carr, Kelly
Danovaro-Holliday, M Carolina
Sodha, Samir V
Prosperi, Christine
Wunderlich, Joshua
Wonodi, Chizoba
Reynolds, Heidi W
Mirza, Imran
Gacic-Dobo, Marta
O'Brien, Katherine L
Lindstrand, Ann
author_facet Shet, Anita
Carr, Kelly
Danovaro-Holliday, M Carolina
Sodha, Samir V
Prosperi, Christine
Wunderlich, Joshua
Wonodi, Chizoba
Reynolds, Heidi W
Mirza, Imran
Gacic-Dobo, Marta
O'Brien, Katherine L
Lindstrand, Ann
author_sort Shet, Anita
collection PubMed
description BACKGROUND: The SARS-CoV-2 pandemic has revealed the vulnerability of immunisation systems worldwide, although the scale of these disruptions has not been described at a global level. This study aims to assess the impact of COVID-19 on routine immunisation using triangulated data from global, country-based, and individual-reported sources obtained during the pandemic period. METHODS: This report synthesised data from 170 countries and territories. Data sources included administered vaccine-dose data from January to December, 2019, and January to December, 2020, WHO regional office reports, and a WHO-led pulse survey administered in April, 2020, and June, 2020. Results were expressed as frequencies and proportions of respondents or reporting countries. Data on vaccine doses administered were weighted by the population of surviving infants per country. FINDINGS: A decline in the number of administered doses of diphtheria–pertussis–tetanus-containing vaccine (DTP3) and first dose of measles-containing vaccine (MCV1) in the first half of 2020 was noted. The lowest number of vaccine doses administered was observed in April, 2020, when 33% fewer DTP3 doses were administered globally, ranging from 9% in the WHO African region to 57% in the South-East Asia region. Recovery of vaccinations began by June, 2020, and continued into late 2020. WHO regional offices reported substantial disruption to routine vaccination sessions in April, 2020, related to interrupted vaccination demand and supply, including reduced availability of the health workforce. Pulse survey analysis revealed that 45 (69%) of 65 countries showed disruption in outreach services compared with 27 (44%) of 62 countries with disrupted fixed-post immunisation services. INTERPRETATION: The marked magnitude and global scale of immunisation disruption evokes the dangers of vaccine-preventable disease outbreaks in the future. Trends indicating partial resumption of services highlight the urgent need for ongoing assessment of recovery, catch-up vaccination strategy implementation for vulnerable populations, and ensuring vaccine coverage equity and health system resilience. FUNDING: US Agency for International Development.
format Online
Article
Text
id pubmed-8691849
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd
record_format MEDLINE/PubMed
spelling pubmed-86918492021-12-22 Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories Shet, Anita Carr, Kelly Danovaro-Holliday, M Carolina Sodha, Samir V Prosperi, Christine Wunderlich, Joshua Wonodi, Chizoba Reynolds, Heidi W Mirza, Imran Gacic-Dobo, Marta O'Brien, Katherine L Lindstrand, Ann Lancet Glob Health Articles BACKGROUND: The SARS-CoV-2 pandemic has revealed the vulnerability of immunisation systems worldwide, although the scale of these disruptions has not been described at a global level. This study aims to assess the impact of COVID-19 on routine immunisation using triangulated data from global, country-based, and individual-reported sources obtained during the pandemic period. METHODS: This report synthesised data from 170 countries and territories. Data sources included administered vaccine-dose data from January to December, 2019, and January to December, 2020, WHO regional office reports, and a WHO-led pulse survey administered in April, 2020, and June, 2020. Results were expressed as frequencies and proportions of respondents or reporting countries. Data on vaccine doses administered were weighted by the population of surviving infants per country. FINDINGS: A decline in the number of administered doses of diphtheria–pertussis–tetanus-containing vaccine (DTP3) and first dose of measles-containing vaccine (MCV1) in the first half of 2020 was noted. The lowest number of vaccine doses administered was observed in April, 2020, when 33% fewer DTP3 doses were administered globally, ranging from 9% in the WHO African region to 57% in the South-East Asia region. Recovery of vaccinations began by June, 2020, and continued into late 2020. WHO regional offices reported substantial disruption to routine vaccination sessions in April, 2020, related to interrupted vaccination demand and supply, including reduced availability of the health workforce. Pulse survey analysis revealed that 45 (69%) of 65 countries showed disruption in outreach services compared with 27 (44%) of 62 countries with disrupted fixed-post immunisation services. INTERPRETATION: The marked magnitude and global scale of immunisation disruption evokes the dangers of vaccine-preventable disease outbreaks in the future. Trends indicating partial resumption of services highlight the urgent need for ongoing assessment of recovery, catch-up vaccination strategy implementation for vulnerable populations, and ensuring vaccine coverage equity and health system resilience. FUNDING: US Agency for International Development. Elsevier Ltd 2021-12-21 /pmc/articles/PMC8691849/ /pubmed/34951973 http://dx.doi.org/10.1016/S2214-109X(21)00512-X Text en © 2022 World Health Organization https://creativecommons.org/licenses/by-nc-nd/3.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
spellingShingle Articles
Shet, Anita
Carr, Kelly
Danovaro-Holliday, M Carolina
Sodha, Samir V
Prosperi, Christine
Wunderlich, Joshua
Wonodi, Chizoba
Reynolds, Heidi W
Mirza, Imran
Gacic-Dobo, Marta
O'Brien, Katherine L
Lindstrand, Ann
Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories
title Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories
title_full Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories
title_fullStr Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories
title_full_unstemmed Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories
title_short Impact of the SARS-CoV-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories
title_sort impact of the sars-cov-2 pandemic on routine immunisation services: evidence of disruption and recovery from 170 countries and territories
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691849/
https://www.ncbi.nlm.nih.gov/pubmed/34951973
http://dx.doi.org/10.1016/S2214-109X(21)00512-X
work_keys_str_mv AT shetanita impactofthesarscov2pandemiconroutineimmunisationservicesevidenceofdisruptionandrecoveryfrom170countriesandterritories
AT carrkelly impactofthesarscov2pandemiconroutineimmunisationservicesevidenceofdisruptionandrecoveryfrom170countriesandterritories
AT danovarohollidaymcarolina impactofthesarscov2pandemiconroutineimmunisationservicesevidenceofdisruptionandrecoveryfrom170countriesandterritories
AT sodhasamirv impactofthesarscov2pandemiconroutineimmunisationservicesevidenceofdisruptionandrecoveryfrom170countriesandterritories
AT prosperichristine impactofthesarscov2pandemiconroutineimmunisationservicesevidenceofdisruptionandrecoveryfrom170countriesandterritories
AT wunderlichjoshua impactofthesarscov2pandemiconroutineimmunisationservicesevidenceofdisruptionandrecoveryfrom170countriesandterritories
AT wonodichizoba impactofthesarscov2pandemiconroutineimmunisationservicesevidenceofdisruptionandrecoveryfrom170countriesandterritories
AT reynoldsheidiw impactofthesarscov2pandemiconroutineimmunisationservicesevidenceofdisruptionandrecoveryfrom170countriesandterritories
AT mirzaimran impactofthesarscov2pandemiconroutineimmunisationservicesevidenceofdisruptionandrecoveryfrom170countriesandterritories
AT gacicdobomarta impactofthesarscov2pandemiconroutineimmunisationservicesevidenceofdisruptionandrecoveryfrom170countriesandterritories
AT obrienkatherinel impactofthesarscov2pandemiconroutineimmunisationservicesevidenceofdisruptionandrecoveryfrom170countriesandterritories
AT lindstrandann impactofthesarscov2pandemiconroutineimmunisationservicesevidenceofdisruptionandrecoveryfrom170countriesandterritories